MAPT and Alzheimer disease: One possibility is that amyloid-β deposition serves as the initial event in both AD and DLB, with the subsequent effects being either tau aggregation, leading to an AD-like clinical presentation, or α-synuclein aggregation, leading to a DLB-like presentation.